Business Standard

Saturday, February 15, 2025 | 10:08 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Healthium to foray into urology space, to invest $5 mn in Kunigal plant

Healthium Medtech has been growing at 30% year-on-year and currently holds around 15-16% share in the Rs 20 billion wound closure market

Healthium Medtech CEO Anish Bafna
Premium

Healthium Medtech CEO Anish Bafna

Samreen Ahmad Bengaluru
After its acquisition by private equity major Apax Partners, India’s biggest surgical and wound care player Healthium Medtech is looking to expand its product portfolio, apart from expanding into newer geographies.

The Bengaluru-based company, formerly known as Sutures India, is planning to enter the urology segment by June. It is also setting up a new line at its existing plant in Kunigal (near Bengaluru), with an investment of $5 million, for urology products.

“The urology space is an evolving space, with a Rs 5-billion market size. We are looking at 15-20 per cent market share in three years,” Anish Bafna, chief executive

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in